Envista Holdings Corporation (NVST)
NVST trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1757073/000175707326000011/0001757073-26-000011-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | NVST on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2019 |
| SEC CIK | 0001757073 |
| SEC industry code | Dental Equipment & Supplies |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.7B |
| Net income | $47.0M |
| Operating income | $216.1M |
| Net margin | 1.7% |
| Operating margin | 7.9% |
| Revenue growth | +8.3% |
| Cash | $1.2B |
| Total assets | $5.7B |
| P/E (computed) | 82.0× |
| P/S (computed) | 1.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-04 |
| Cash and burn | $1.2B cash; operating cash flow $75.5M a quarter. | Report 2026-10-02 |
| Shares outstanding | 160,344,938 (2026-10-30); 164,426,233 a year earlier; 171,402,370 three years earlier. | Cover page 2026-10-30 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-11-09 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Ernst & Young LLP, Irvine, California, United States | PCAOB Form AP 2026-02-26 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $510K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-10-02 | $691.5M | $508.3M | $77.9M | $1.2B | $1.4B | $2.9B | 10-Q 2026-11-04 |
| Q2 2026 2026-07-03 | $730.5M | $53.7M | $119.2M | $1.1B | $1.4B | $2.9B | 10-Q 2026-08-05 |
| Q1 2026 2026-04-03 | $705.5M | $38.7M | -$3.3M | $1.1B | $1.4B | $2.8B | 10-Q 2026-05-06 |
| Q4 2025 2025-12-31 | $750.6M | $32.9M | $108.0M | $1.2B | $1.4B | $2.7B | 10-K 2026-02-12 |
| Q3 2025 2025-09-26 | $669.9M | -$30.3M | $78.7M | $1.1B | $1.4B | $2.6B | 10-Q 2026-11-04 |
| Q2 2025 2025-06-27 | $682.1M | $26.4M | $88.7M | $1.1B | $1.4B | $2.6B | 10-Q 2026-08-05 |
| Q1 2025 2025-03-28 | $616.9M | $18.0M | $300K | $1.1B | $1.5B | $2.5B | 10-Q 2026-05-06 |
| Q4 2024 2024-12-31 | $652.9M | $1.2M | $132.4M | $1.1B | $1.5B | $2.5B | 10-K 2026-02-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B2 | 2026-11-12 |
| Latest annual report | 10-K | 2026-02-12 |
| Latest quarterly / interim | 10-Q | 2026-11-04 |
| Latest current report | 8-K | 2026-11-04 |
| Latest proxy | DEFA14A | 2026-04-07 |
Source: SEC EDGAR submissions feed, 561 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -2.7% |
| 1 month | +8.1% |
| 3 months | -12.8% |
| Year to date | +12.8% |
| 1 year | +23.1% |
| From 52-week high | -19.1% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| HTFL | Heartflow Inc. | $46.86 | -3.30% | $4.1B |
| STVN | Stevanato Group S.p.A. | $15.53 | -1.71% | $4.2B |
| PLSE | Pulse Biosciences Inc Common Stock (DE) | $46.36 | -8.09% | $3.4B |
| ICUI | ICU Medical Inc. | $181.87 | +1.45% | $4.5B |
| IRTC | iRhythm Holdings Inc. | $90.83 | -1.18% | $3.1B |
| VVVV | vVARDIS Holding AG | $16.00 | -3.03% | $2.9B |
| MMSI | Merit Medical Systems Inc. | $86.35 | -0.32% | $5.2B |
| MMED | MiniMed Group Inc. | $18.65 | +3.67% | $5.2B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier